Pakistan | News | COVAX Facility delivers second consignment of US-donated Moderna COVID-19 vaccines to Pakistan

COVAX Facility delivers second consignment of US-donated Moderna COVID-19 vaccines to Pakistan

Print PDF

A total of 8 million doses of COVID-19 vaccines have been delivered to Pakistan by the COVAX Facility, the global COVID-19 vaccine equity scheme, so far
A total of 8 million doses of COVID-19 vaccines have been delivered to Pakistan by the COVAX Facility, the global COVID-19 vaccine equity scheme, so far

Islamabad, 26 July 2021 – Yesterday a second consignment of 3 million doses of Moderna (mRNA-1273) COVID-19 vaccines donated by the Government of the United States to the COVAX Facility have arrived in Pakistan, bringing the total doses donated by the US Government to Pakistan through COVAX to 5.5 million since 8 May. 

The donation is part of the 870 million additional COVID-19 vaccine doses pledged by the G7 through the COVAX Facility dose-sharing mechanism to support global equitable access to vaccines in 2021 and 2022, with the aim to deliver at least half by the end of 2021. 

COVAX, the global COVID-19 vaccine equity scheme, has delivered a total 8 million doses of vaccine to Pakistan since 8 May, including 2.5 million doses of AstraZeneca, 100 000 doses Pfizer and 5.5 million doses of Moderna COVID-19 vaccines. 

To date, close to 7 million people have been fully vaccinated and nearly 20 million partially vaccinated in Pakistan since the start of the national vaccination campaign in February 2021. 

The number of confirmed COVID-19 cases in Pakistan has now reached close to a million, while nearly 23 000 people are reported to have succumbed to the disease.

“Despite national, regional and global efforts, the pandemic is nowhere near finished. WHO will continue to work with the Government of Pakistan and donors to implement activities to control transmission and advocate for equitable vaccine access and distribution. Vaccines are key in the fight again COVID-19 and we encourage everyone to get their vaccine immediately,” says Dr Palitha Mahipala, WHO Representative in Pakistan. “We thank the US Government for expressing their solidarity with Pakistan through this donation. Nobody is safe until everyone is safe.”

The allocation of extra doses of COVID-19 vaccines by G7 countries to COVAX will not only limit the spread of the coronavirus COVID-19, it will also prevent new variants from emerging.  

“UNICEF thanks the Government of the United States for its generous contribution to the COVAX dose-sharing mechanism. This is an important step in the continued fight against COVID-19. UNICEF commends the Government of Pakistan for its leadership in ensuring a smooth roll-out of the COVID-19 vaccination campaign and urges the population to get vaccinated and continue taking COVID-19 precautionary measures,” said Aida Girma, UNICEF Representative in Pakistan. “UNICEF will continue to support the national response to COVID-19 campaign in Pakistan through procurement services of essential COVID-19 supplies; expansion of cold chain capacity to ensure safe storage of vaccines; risk communication and community engagement to increase vaccine uptake and enforce SOPs and efficient and effective management of the COVID-19 Call Centre 1166.” 

Strictly complying with COVID-19 public health and social measures continues to be critical to stop the spread of virus, after getting vaccinated. These include regularly wearing face masks, washing hands with soap for at least 20 seconds or use a sanitizer; remaining at least 6x feet away from other people; avoiding crowded places; and staying at home and seeking care when having COVID-19 symptoms. 

The goal of COVAX is to help address the acute phase of the global pandemic by the end of 2021 by providing rapid, fair and equitable access to safe and effective vaccines for all participating countries and territories regardless of income level.

The COVAX Facility, co-led by Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO, together with UNICEF, aims to provide access to quality-assured COVID-19 vaccines, enabling the protection of frontline health care and social workers, as well as other high-risk and vulnerable groups.    

For more information, please contact:

UNICEF

Catherine Weibel
UNICEF Pakistan
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
+92 300 500 2592


Abdul Sami Malik
UNICEF Pakistan
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
+92 300 855 6654

WHO

Maryam Yunus
WHO Pakistan
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
+92 300 8441744

Notes to editors

So far donors to the COVAX Advance Market Commitment include Austria, Belgium, Denmark, Estonia, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Netherlands, Norway, Spain, Sweden, European Union, Australia, Bhutan, Canada, Colombia, Japan, Korea, Kuwait, Monaco, New Zealand, Qatar, Saudi Arabia, Singapore, Switzerland, United Kingdom, United States, Anonymous Foundation, Bill & Melinda Gates Foundation, KS Relief/Gamers Without Borders, Mastercard, Medline International, Nikkei Inc., Reed Hastings and Patty Quillin, Shell, Thistledown Foundation, TikTok, Transferwise, Soccer Aid.

List of donor pledges to COVAX AMC

About COVAX

COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator, is co-led by CEPI, Gavi and WHO – working in partnership with developed and developing country vaccine manufacturers, UNICEF, the World Bank, and others. It is the only global initiative that is working with governments and manufacturers to ensure COVID-19 vaccines are available worldwide to both higher-income and lower-income countries.

CEPI is leading on the COVAX vaccine research and development portfolio, investing in R&D across a variety of promising candidates, with the goal to support development of three safe and effective vaccines which can be made available to countries participating in the COVAX Facility. As part of this work, CEPI has secured first right of refusal to potentially over one billion doses for the COVAX Facility to a number of candidates, and made strategic investments in vaccine manufacturing, which includes reserving capacity to manufacture doses of COVAX vaccines at a network of facilities, and securing glass vials to hold 2 billion doses of vaccine. CEPI is also investing in the ‘next generation’ of vaccine candidates, which will give the world additional options to control COVID-19 in the future.

Gavi leads on procurement and delivery at scale for COVAX: designing and managing the COVAX Facility and the Gavi COVAX AMC and working with its traditional Alliance partners UNICEF and WHO, along with governments, on country readiness and delivery. As part of this role, Gavi hosts the Office of the COVAX Facility to coordinate the operation and governance of the mechanism as a whole, holds financial and legal relationships with 193 Facility participants, and manages the COVAX Facility deals portfolio: negotiating advance purchase agreements with manufacturers of promising vaccine candidates to secure doses on behalf of all COVAX Facility participants. Gavi also coordinates design, operationalisation and fundraising for the Gavi COVAX AMC, the mechanism that provides access to donor-funded doses of vaccine to 92 lower-income economies. As part of this work, Gavi provides funding and oversight for UNICEF procurement and delivery of vaccines to all AMC participants – operationalising the advance purchase agreements between Gavi and manufacturers – as well as support for partners’ and governments work on readiness and delivery. This includes tailored support to governments, UNICEF, WHO and other partners for cold chain equipment, technical assistance, syringes, vehicles, and other aspects of the vastly complex logistical operation for delivery. Gavi also co-designed, raises funds for and supports the operationalisation of the AMC’s no-fault compensation mechanism as well as the COVAX Humanitarian Buffer.

WHO has multiple roles within COVAX: It provides normative guidance on vaccine policy, regulation, safety, R&D, allocation, and country readiness and delivery. Its Strategic Advisory Group of Experts (SAGE) on Immunization develops evidence-based immunization policy recommendations. Its Emergency Use Listing (EUL)/prequalification programmes ensure harmonized review and authorization across member states. It provides global coordination and member state support on vaccine safety monitoring. It developed the target product profiles for COVID-19 vaccines and provides R&D technical coordination. WHO leads, along with UNICEF, the support to countries as they prepare to receive and administer vaccines. The Country Readiness and Delivery (CRD) workstream includes Gavi and numerous other partners working at the global, regional, and country-level to provide tools, guidance, monitoring, and on the ground technical assistance for the planning and roll-out of the vaccines. Along with COVAX partners, WHO is also developing a no-fault compensation scheme as part of the time-limited indemnification and liability commitments.

UNICEF is leveraging its experience as the largest single vaccine buyer in the world and working with manufacturers and partners on the procurement of COVID-19 vaccine doses, as well as freight, logistics and storage. UNICEF already procures more than 2 billion doses of vaccines annually for routine immunization and outbreak response on behalf of nearly 100 countries. In collaboration with the PAHO Revolving Fund, UNICEF is leading efforts to procure and supply doses of COVID-19 vaccines for COVAX. In addition, UNICEF, Gavi and WHO are working with governments around the clock to ensure that countries are ready to receive the vaccines, with appropriate cold chain equipment in place and health workers trained to dispense them. UNICEF is also playing a lead role in efforts to foster trust in vaccines, delivering vaccine confidence communications and tracking and addressing misinformation around the world.

###

About Gavi, the Vaccine Alliance
Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate half the world’s children against some of the world’s deadliest diseases. Since its inception in 2000, Gavi has helped to immunise a whole generation – over 822 million children – and prevented more than 14 million deaths, helping to halve child mortality in 73 lower-income countries. Gavi also plays a key role in improving global health security by supporting health systems as well as funding global stockpiles for Ebola, cholera, meningitis and yellow fever vaccines. After two decades of progress, Gavi is now focused on protecting the next generation and reaching the unvaccinated children still being left behind, employing innovative finance and the latest technology – from drones to biometrics – to save millions more lives, prevent outbreaks before they can spread and help countries on the road to self-sufficiency. Learn more at www.gavi.org and connect with us on Facebook and Twitter.

The Vaccine Alliance brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry, technical agencies, civil society, the Bill & Melinda Gates Foundation and other private sector partners. View the full list of donor governments and other leading organizations that fund Gavi’s work here.

About UNICEF
UNICEF works in some of the world’s toughest places, to reach the world’s most disadvantaged children. Across 190 countries and territories, we work for every child, everywhere, to build a better world for everyone. For more information about UNICEF and its work for children, visit www.unicef.org and www.unicef.org/pakistan. For more information about COVID-19, visit www.unicef.org/coronavirus. Find out more about UNICEF’s work on the COVID-19 vaccines here, or about UNICEF’s work on immunization here. Follow UNICEF Pakistan on Twitter, Facebook and Instagram.

About WHO
The World Health Organization provides global leadership in public health within the United Nations system. Founded in 1948, WHO works with 194 Member States, across six regions and from more than 150 offices, to promote health, keep the world safe and serve the vulnerable. Our goal for 2019-2023 is to ensure that a billion more people have universal health coverage, to protect a billion more people from health emergencies, and provide a further billion people with better health and wellbeing.
 For updates on COVID-19 and public health advice to protect yourself from coronavirus, visit www.who.int and follow WHO on TwitterFacebookInstagramLinkedInTikTokPinterestSnapchatYouTube. Follow WHO Pakistan on Twitter and Facebook.